Real-World Treatment Outcomes of Early vs Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Crohn's & Colitis 360
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis
Crohns Colitis 360 2024 Oct 01;6(4)otae061, N Krugliak Cleveland, N Candela, JA Carter, M Kuharic, J Qian, Z Tang, R Turpin, DT RubinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.